详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Interventional Radiology, Shandong Cancer Hospital and Institute Affiliated Shandong First Medical University, Shandong Academy of Medical Sciences, China [2]NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, China

出处：

DOI：

ISSN：

关键词： MAFLD HSCs Fat metabolism Metabolic disease Tumor immune microenvironment MAFLD related HCC

摘要：

Metabolic associated fatty liver disease (MAFLD) is a significant risk factor for the development of hepatocellular carcinoma (HCC). Hepatic stellate cells (HSCs), as key mediators in liver injury response, are believed to play a crucial role in the repair process of liver injury. However, in MAFLD patients, the normal metabolic and immunoregulatory mechanisms of HSCs become disrupted, leading to disturbances in the local microenvironment. Abnormally activated HSCs are heavily involved in the initiation and progression of HCC. The metabolic disorders and abnormal activation of HSCs not only initiate liver fibrosis but also contribute to carcinogenesis. In this review, we provide an overview of recent research progress on the relationship between the abnormal metabolism of HSCs and the local immune system in the liver, elucidating the mechanisms of immune imbalance caused by abnormally activated HSCs in MAFLD patients. Based on this understanding, we discuss the potential and challenges of metabolic-based and immunology-based mechanisms in the treatment of MAFLD-related HCC, with a specific focus on the role of HSCs in HCC progression and their potential as targets for anti-cancer therapy. This review aims to enhance researchers' understanding of the importance of HSCs in maintaining normal liver function and highlights the significance of HSCs in the progression of MAFLD-related HCC.Copyright © 2024 Elsevier B.V. All rights reserved.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版中科院分区表Review为是的期刊

：

大类 | 1 区

医学

小类 | 2 区生化与分子生物学 2 区生物物理 2 区肿瘤学

最新[2023]版

：

大类 | 1 区

医学

小类 | 2 区生化与分子生物学 2 区生物物理 2 区肿瘤学

第一作者：

第一作者机构： [1]Department of Interventional Radiology, Shandong Cancer Hospital and Institute Affiliated Shandong First Medical University, Shandong Academy of Medical Sciences, China

通讯作者：

通讯机构： [1]Department of Interventional Radiology, Shandong Cancer Hospital and Institute Affiliated Shandong First Medical University, Shandong Academy of Medical Sciences, China [*1]Department of Interventional Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, No. 440, Jiyan Road, Ji’nan, Shandong Province, CN 250117, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]缺氧肿瘤微环境中外泌体参与免疫调控的研究进展 [2]Brown-fat-mediated tumour suppression by cold-altered global metabolism [3]Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment. [4]Tumor immune microenvironment-modulated nanostrategy for the treatment of lung cancer metastasis [5]Immune Profiles of Tumor Microenvironment and Clinical Prognosis among Women with Triple-Negative Breast Cancer. [6]The role of long non-coding RNAs in carbohydrate and fat metabolism in the liver [7]Aspect ratio-dependent dual-regulation of the tumor immune microenvironment against osteosarcoma by hydroxyapatite nanoparticles [8]Establishment of a tumor immune microenvironment-based molecular classification system of breast cancer for immunotherapy. [9]Gut and obesity/metabolic disease: Focus on microbiota metabolites [10]Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency.